Literature DB >> 16445620

Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells.

S C J P Gielen1, E E Hanekamp, P Hanifi-Moghaddam, A M Sijbers, A J van Gool, C W Burger, L J Blok, F J Huikeshoven.   

Abstract

Estrogen-stimulated growth of the malignant human endometrium can be balanced by the differentiating properties of progesterone. To study the molecular basis behind this, gene expression profiling was performed using complementary DNA microarray analysis. In this study, the human endometrial cancer cell lines ECC-1 and PRAB-36 were used as models. The ECC-1 cell line, which expresses high levels of estrogen receptor alpha and is stimulated in growth by estrogens, was used to study estrogen regulation of gene expression. The Ishikawa sub-cell line PRAB-36, expressing both PRA and PRB, progesterone receptor isoforms, and inhibited in growth by progestagens, was used to study progesterone regulation of gene expression. Using these two well-differentiated human endometrial cancer cell lines, 148 estrogen- and 148 progesterone-regulated genes were identified. After functional classification, the estrogen- and progesterone-regulated genes could be categorized in different biologically relevant groups. Within the group of "cell growth and/or maintenance," 81 genes were clustered, from which a number of genes could be involved in arranging the cross talk that exists between estrogen and progesterone signaling. On the basis of analysis of the current findings, it is hypothesized that cross talk between estrogen and progestagen signaling does not occur by counterregulation of single genes, but rather at the level of differential regulation of different genes within the same functional families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16445620     DOI: 10.1111/j.1525-1438.2006.00279.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

1.  The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus.

Authors:  Matthew Dean; Julia Austin; Ren Jinhong; Michael E Johnson; Daniel D Lantvit; Joanna E Burdette
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869

2.  Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.

Authors:  Jung-Ho Lee; Matthew Dean; Julia R Austin; Joanna E Burdette; Brian T Murphy
Journal:  J Nat Prod       Date:  2018-09-10       Impact factor: 4.050

Review 3.  Role of nuclear progesterone receptor isoforms in uterine pathophysiology.

Authors:  Bansari Patel; Sonia Elguero; Suruchi Thakore; Wissam Dahoud; Mohamed Bedaiwy; Sam Mesiano
Journal:  Hum Reprod Update       Date:  2014-11-18       Impact factor: 15.610

4.  Inhibitors of Myelination and Remyelination, Bone Morphogenetic Proteins, are Upregulated in Human Neurological Disease.

Authors:  Judith B Grinspan
Journal:  Neurochem Res       Date:  2020-02-06       Impact factor: 3.996

5.  Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population.

Authors:  Wang-Hong Xu; Ji-Rong Long; Wei Zheng; Zhi-Xian Ruan; Qiuyin Cai; Jia-Rong Cheng; Yong-Bing Xiang; Xiao-Ou Shu
Journal:  Cancer       Date:  2009-06-15       Impact factor: 6.860

6.  Transcriptional activation of insulin-like growth factor binding protein 6 by 17beta-estradiol in SaOS-2 cells.

Authors:  Yu-yan Zhao; Lei Guo; Xiao-juan Zhao; Hong Liu; Tian Lei; Dong-jie Ma; Xiao-yu Gao
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

Review 7.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

8.  Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes.

Authors:  Jens K Habermann; Nana K Bündgen; Timo Gemoll; Sampsa Hautaniemi; Caroline Lundgren; Danny Wangsa; Jana Doering; Hans-Peter Bruch; Britta Nordstroem; Uwe J Roblick; Hans Jörnvall; Gert Auer; Thomas Ried
Journal:  Mol Cancer       Date:  2011-10-31       Impact factor: 27.401

Review 9.  Ion Channels in Endometrial Cancer.

Authors:  Bruna Pasqualotto Costa; Fernanda Bordignon Nunes; Francini Corrêa Noal; Gisele Branchini
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

10.  Expression and clinical significance of FXYD3 in endometrial cancer.

Authors:  Yifei Li; Xia Zhang; Shuwen Xu; Jing Ge; Jing Liu; Lin Li; Guiying Fang; Yali Meng; Hongzhen Zhang; Xiaofeng Sun
Journal:  Oncol Lett       Date:  2014-05-23       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.